In humans, adiponectin has been reported to inhibit the proliferation of both normal and ectopic endometrial cells in a dose- and time-dependent manner (Bohlouli et al., 2013,2016), thereby playing a potentially important role in the pathological processes that lead to EMs. Here, ADIPOQ is linked to eosinophilia-myalgia syndrome.